While T cells as source of IL-22 in lung cancer have not been proposed prior to our study, our data are supported by evidence from other tumor types such as colon, gastric or hepatic carcinomas where CD4 T cells are thought to be the main sources of IL-22 [24–26]. The gene discussed is CD4; the disease is lung carcinoma.